Heparin-induced thrombocytopenia primary prevention: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
 
Primary preventions focuses on interventions that will prevent the onset of a disease before the disease process begins.


==Primary Prevention==
==Primary Prevention==
 
Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.<ref name="pmid20059332">{{cite journal| author=Arepally GM, Ortel TL| title=Heparin-induced thrombocytopenia. | journal=Annu Rev Med | year= 2010 | volume= 61 | issue=  | pages= 77-90 | pmid=20059332 | doi=10.1146/annurev.med.042808.171814 | pmc=4153429 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20059332  }} </ref> Avoidance of orthopedic or cardiac surgeries can be primary preventive measures also. Other risk factors for HIT are non-modifiable and thus there are no other primary prevention strategies for HIT.


==Reference==
==Reference==

Revision as of 01:34, 31 July 2017

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia primary prevention

CDC on Heparin-induced thrombocytopenia primary prevention

Heparin-induced thrombocytopenia primary prevention in the news

Blogs on Heparin-induced thrombocytopenia primary prevention

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Overview

Primary preventions focuses on interventions that will prevent the onset of a disease before the disease process begins.

Primary Prevention

Primary prevention for HIT focuses on avoidance of heparin or heparin products. If there is no exposure to heparin, HIT cannot develop. For patients who much receive heparin, the use of low molecular weight heparin is preferred over unfractionated heparin with regards to prevention of HIT.[1] Avoidance of orthopedic or cardiac surgeries can be primary preventive measures also. Other risk factors for HIT are non-modifiable and thus there are no other primary prevention strategies for HIT.

Reference

  1. Arepally GM, Ortel TL (2010). "Heparin-induced thrombocytopenia". Annu Rev Med. 61: 77–90. doi:10.1146/annurev.med.042808.171814. PMC 4153429. PMID 20059332.

Template:WS Template:WH